<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on June 22, 2026 at 9:54 pm by All in One SEO v4.9.8 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://corteneinc.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Cortene</title>
		<link><![CDATA[https://corteneinc.com]]></link>
		<description><![CDATA[Cortene]]></description>
		<lastBuildDate><![CDATA[Wed, 31 Jul 2024 01:19:06 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://corteneinc.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://corteneinc.com/company/]]></guid>
			<link><![CDATA[https://corteneinc.com/company/]]></link>
			<title>Company</title>
			<pubDate><![CDATA[Wed, 31 Jul 2024 01:19:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://corteneinc.com/]]></guid>
			<link><![CDATA[https://corteneinc.com/]]></link>
			<title>Home</title>
			<pubDate><![CDATA[Tue, 02 Jul 2024 13:02:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://corteneinc.com/part-iii-a-new-drug-for-chronic-fatigue-syndrome-me-cfs-the-clinical-trial/]]></guid>
			<link><![CDATA[https://corteneinc.com/part-iii-a-new-drug-for-chronic-fatigue-syndrome-me-cfs-the-clinical-trial/]]></link>
			<title>[Part III] A New Drug for Chronic Fatigue Syndrome (ME/CFS): The Clinical Trial</title>
			<pubDate><![CDATA[Thu, 16 May 2024 10:14:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://corteneinc.com/part-ii-a-new-drug-a-new-hypothesis-for-chronic-fatigue-syndrome-me-cfs/]]></guid>
			<link><![CDATA[https://corteneinc.com/part-ii-a-new-drug-a-new-hypothesis-for-chronic-fatigue-syndrome-me-cfs/]]></link>
			<title>[Part II] A New Drug &#038; A New Hypothesis For Chronic Fatigue Syndrome (ME/CFS)</title>
			<pubDate><![CDATA[Thu, 16 May 2024 10:09:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://corteneinc.com/part-i-the-cortene-way-new-drug-to-be-trialed-in-chronic-fatigue-syndrome-me-cfs-soon/]]></guid>
			<link><![CDATA[https://corteneinc.com/part-i-the-cortene-way-new-drug-to-be-trialed-in-chronic-fatigue-syndrome-me-cfs-soon/]]></link>
			<title>[Part I] The Cortene Way: New Drug to Be Trialed in Chronic Fatigue Syndrome (ME/CFS) Soon</title>
			<pubDate><![CDATA[Thu, 16 May 2024 10:08:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://corteneinc.com/the-cortene-chronic-fatigue-syndrome-me-cfs-drug-trial-begins/]]></guid>
			<link><![CDATA[https://corteneinc.com/the-cortene-chronic-fatigue-syndrome-me-cfs-drug-trial-begins/]]></link>
			<title>The Cortene Chronic Fatigue Syndrome (ME/CFS) Drug Trial Begins</title>
			<pubDate><![CDATA[Thu, 16 May 2024 10:07:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://corteneinc.com/acute-corticotropin-releasing-factor-receptor-type-2-agonism-results-in-sustained-symptom-improvement-in-myalgic-encephalomyelitis-chronic-fatigue-syndrome/]]></guid>
			<link><![CDATA[https://corteneinc.com/acute-corticotropin-releasing-factor-receptor-type-2-agonism-results-in-sustained-symptom-improvement-in-myalgic-encephalomyelitis-chronic-fatigue-syndrome/]]></link>
			<title>Acute Corticotropin-Releasing Factor Receptor Type 2 Agonism Results in Sustained Symptom Improvement in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome</title>
			<pubDate><![CDATA[Thu, 13 Jun 2024 10:25:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://corteneinc.com/cortene-to-move-forward-on-new-drug-for-chronic-fatigue-syndrome-me-cfs/]]></guid>
			<link><![CDATA[https://corteneinc.com/cortene-to-move-forward-on-new-drug-for-chronic-fatigue-syndrome-me-cfs/]]></link>
			<title>Cortene to Move Forward on New Drug for Chronic Fatigue Syndrome (ME/CFS)</title>
			<pubDate><![CDATA[Thu, 13 Jun 2024 10:19:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://corteneinc.com/contact-us/]]></guid>
			<link><![CDATA[https://corteneinc.com/contact-us/]]></link>
			<title>Contact Us</title>
			<pubDate><![CDATA[Mon, 17 Jun 2024 08:40:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://corteneinc.com/news/]]></guid>
			<link><![CDATA[https://corteneinc.com/news/]]></link>
			<title>News</title>
			<pubDate><![CDATA[Mon, 17 Jun 2024 04:38:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://corteneinc.com/science/]]></guid>
			<link><![CDATA[https://corteneinc.com/science/]]></link>
			<title>Science</title>
			<pubDate><![CDATA[Mon, 17 Jun 2024 04:02:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://corteneinc.com/pipeline/]]></guid>
			<link><![CDATA[https://corteneinc.com/pipeline/]]></link>
			<title>Pipeline</title>
			<pubDate><![CDATA[Mon, 17 Jun 2024 04:00:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://corteneinc.com/sample-page/]]></guid>
			<link><![CDATA[https://corteneinc.com/sample-page/]]></link>
			<title>Sample Page</title>
			<pubDate><![CDATA[Mon, 15 Apr 2024 09:33:34 +0000]]></pubDate>
		</item>
				</channel>
</rss>
